A comprehensive treatise on new developments in biotechnology, the authors of Biotechnology and Safety Assessment, 3e, bring readers an up-to-date review of food safety issues, pre-clinical safety and development of new foods and drugs, plant biotechnology, food allergies and safety assessment, and consumer benefits with regard to genetically modified food. Tomorrow's foods will be obtained from genetically modified crops, offering consumers higher nutritional value and more of it. Our medications will be obtained through a variety of biotechnological procedures yielding more potent and specific medications for diseases and vaccines. In order to make this view of the future come to light, John A. Thomas and Roy L. Fuchs have updated their classic in order to keep readers one step ahead. Written by internationally recognized molecular biologists, plant agronomists, microbiologists, toxicologists, nutritionists, and regulatory authorities, this third edition is an excellent and authoritative resource, making it a valuable resource to any biomedical library or scientific bookshelf. - Provides timely coverage on topics of agribiotechnology and biotherapeutics - Describes the recent progress in genetically modified crops and their safety - Presents an update of the newer developments in therapeutic agents - Discusses role of genetically modified microorganisms in the development of new food products - Outlines various global regulatory issues relating to GM crops - Addresses environmental and ecological topics related to GM crops

Thoroughly updated and revised, this second edition of Biotechnology and Safety Assessment represents a timely update on the rapidly moving field of biopharmaceutics. While the focus is on the therapeutic potentials of various cytokines and antisense agents, the book also identifies some of the toxicologic considerations of interferons and of genetically engineered food. Experts front academia, industry, and government address risk assessment and environmental issues associated with the expanding worldwide consumption of genetically engineered foodstuffs. A series of contemporary views are also offered on the advances in both mammalian and plant genetics and how these advances contribute to safer biotherapeutic agents and more nutritious foods. Toxicologists, pharmacologists, regulatory agency professionals, environmental scientists, nutritionists, and agricultural specialists will find this book to be an essential reference on the biotechnology and toxicological safety assessment of drugs and other xenobiotics. Book jacket.

This series represents a compilation of the biosafety consensus documents developed by the OECD Working Group on Harmonisation of Regulatory Oversight in Biotechnology over the periods 2011-12 (Volume 5) and 2013-15 (Volume 6).

Between 1973 and 2016, the ways to manipulate DNA to endow new characteristics in an organism (that is, biotechnology) have advanced, enabling the development of products that were not previously possible. What will the likely future products of biotechnology be over the next 5â€"10 years? What scientific capabilities, tools, and/or expertise may be needed by the regulatory agencies to ensure they make efficient and sound evaluations of the likely future products of biotechnology? Preparing for Future Products of Biotechnology analyzes the future landscape of biotechnology products and seeks to inform forthcoming policy making. This report identifies potential new risks and frameworks for risk assessment and areas in which the risks or lack of risks relating to the products of biotechnology are well understood.

With contributions from internationally recognized experts, Food Safety of Proteins in Agricultural Biotechnology comprehensively addresses how toxicology testing of proteins should be accomplished and how protein safety assessments should be carried out. Beginning with a background on protein biology, the book delineates the fundamental difference

These OECD Biosafety Consensus Documents identify elements of scientific information used in the environmental safety and risk assessment of transgenic organisms which are common to OECD member countries and some non members associated with the work.

Genetic-based animal biotechnology has produced new food and pharmaceutical products and promises many more advances to benefit humankind. These exciting prospects are accompanied by considerable unease, however, about matters such as safety and ethics. This book identifies science-based and policy-related concerns about animal biotechnologyâ€"key issues that must be resolved before the new breakthroughs can reach their potential. The book includes a short history of the field and provides understandable definitions of terms like cloning. Looking at technologies on the near horizon, the authors discuss what we know and what we fear about their effectsâ€"the inadvertent release of dangerous microorganisms, the safety of products derived from biotechnology, the impact of genetically engineered animals on their environment. In addition to these concerns, the book explores animal welfare concerns, and our societal and institutional capacity to manage and regulate the technology and its products. This accessible volume will be important to everyone interested in the implications of the use of animal biotechnology.

Biotechnology Risk Assessment: Issues and Methods for Environmental Introductions tackles the environmental concerns associated with utilizing contemporary biotechnology. The title also examines the methods of implementing biotechnology while also minimizing the risks. The text first covers the suitability and applicability of risk assessment methods for environmental applications of biotechnology, and then proceeds to tackling the methods for evaluation of microorganism properties. Next, the selection deals with human exposure to viruses and genetically altered bacteria. The text also tackles the effects of bioengineered organisms on the ecosystem, along with the assessment of the transport and fate of bioengineered microorganisms in the environment. The seventh chapter discusses the analysis of the function and structure of ecosystem, while the eighth chapter details the controlled testing and monitoring methods for microorganisms. The book will be of great use to biotechnologists, microbiologists, ecologists, epidemiologists, and virologists.

These OECD Biosafety Consensus Documents identify elements of scientific information used in the environmental safety and risk assessment of transgenic organisms which are common to OECD member countries and some non members associated with the work.

This updated text explains how advances in mammalian and plant genetics contribute to better therapeutics agents and more wholesome foods. It addresses such topics as new pharmaceutical agents, agribiotechnology, safety evaluation of biotechnology-derived drugs, food safety, nutritional science, and regulatory and environmental aspects of genetically-modified organisms. New to this edition are chapters on biotherapeutics and herbicide-resistant crops. It should be of interest to biotechnology, toxicologists, pharmaceutical scientists, environmental scientists and agriculturists.